⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX CLASS ACTION: MoonLake Immunotherapeutics Sued for Securities Fraud after 90% Stock Drop - Investors Urged to Contact BFA Law before December 15 Deadline
accessnewswire.com
MLTX
Levi & Korsinsky Moves to SueWallSt For MoonLake Immunotherapeutics Investors That Lost Money
accessnewswire.com
MLTX
MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms
globenewswire.com
MLTX
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
globenewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
MLTX
MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
prnewswire.com
MLTX
DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025
prnewswire.com
MLTX
MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action
globenewswire.com
MLTX
SueWallSt Podcast Update: Levi & Korsinsky Details MLTX Class Action Claims
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
MLTX